Percheron Therapeutics LimitedASX: PER

ATL1102 for Multiple Sclerosis Phase IIb trial Update

Jul 27, 2017 at 3:59 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment